The comparison effects of pethidine, warm intravenous fluids and combination warming (warm intravenous fluids with humid warm oxygen) on severity of postoperative shivering by general anesthesia patients in recovery room

The comparison effects of three methods:Pethidine, warm intravenous fluids and combination warming (warm intravenous fluids with humid warm oxygen) on severity of postoperative shivering

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014012016278N1

Enrollment

Registered

2014-06-25

Start date

2014-05-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shivering. Complications of surgical and medical care, not elsewhere classified

Interventions

Intervention 1: combination warming(intravenous warming serum and humid warm oxygen 8lit/min). Intervention 2: warm intravenous fluids(38 ° C ringer serum). Intervention 3: intravenous pethidin 0.4mg

Treatment - Drugs

combination warming(intravenous warming serum and humid warm oxygen 8lit/min)

warm intravenous fluids(38 ° C ringer serum)

intravenous pethidin 0.4mg/kg

Eligibility

Sex/Gender

All

Age

19 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:operation under general anesthesia? individuals 20-60years? the category of America Society of Anesthesiology (ASA) are class 1 and 2, ASA1 ( people with normal health without systemic diseases such as heart disease and respiratory and endocrine and... ) ASA2 ( people that have a mild controlled systemic disease and not limit the patient) ;degree1,2,3 of shivering; normothermic patients :the oral temperature will be between 36/5 to 37/5° C ;the lack of reception ( corticosteroids, non steroidal analgesics , anti hypertensive drugs , anti seizure drugs); lack of received blood and blood products;patient without BP and SPO2 changes;consent to participate up to the end study. Exclusion criteria :spinal anesthesia;individuals below20 and up 60 years ; ASA 3,4 such as( endocrine disorders , cardiovascular diseases , hypertension, ischemic heart disease , obstructive lung disease and cerebral palsy patient and... ) ;fever;addiction;hyperthermia and hypothermia; reception( corticosteroids, non steroidal analgesics , anti hypertensive drugs , anti seizure drugs); received blood and blood products ; degree 4 of shivering ;patients who will not consent to participate up to the end study ; patients with BP changes are more 5mm/ hg ;decrease in spo2 than 15%.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Shivering. Timepoint: Postoperative. Method of measurement: Patient Observation.	—

Secondary

Measure	Time frame
Temperature. Timepoint: Postoperative. Method of measurement: Tympanic thermometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAyob Akbari

Birjand University of Medical Sciences

akbari_ayob@bums.ac.ir armin_623@ymail.com+98 56 1225 8275

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026